Jurors in Atlantic City, N.J., assessed punitive damages of $27.5 million against Merck & Co. for marketing its painkiller Vioxx without properly warning of its significant cardiovascular risks.
The punitive award came late on Monday, hours after the jury found that the drug and the failure to warn contributed to plaintiff Frederick Humeston’s heart attack, which occurred five months before Merck changed the product’s label and three years before the product was taken off the market.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
